Clinical trial
Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer
NCT00429299
Study timeline
Study start (unknown)2006-08-01Date precision: month
Registry last updated2016-03-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Neoplasms, Breastunresolved
Interventions
lapatinibDRUG · verified · RxNorm: lapatinib
trastuzumabBIOLOGICAL
paclitaxelDRUG · verified · RxNorm: paclitaxel
fluorouracilDRUG · verified · RxNorm: fluorouracil
epidoxorubicinDRUG
cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00429299 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.